echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > ASCO 2021: Summary Overview and Outlook 18 | Impact of COVID-19 on the diagnosis of breast and colorectal cancer

    ASCO 2021: Summary Overview and Outlook 18 | Impact of COVID-19 on the diagnosis of breast and colorectal cancer

    • Last Update: 2021-06-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Effective cancer screening has greatly increased the detection rate of early cancers, and at the same time, improved the incidence of advanced cancer diagnosis .


    Screening for diagnosis of breast cancer and colorectal cancer The COVID-19 pandemic has caused many cancer screening programs to be postponed or cancelled.


    In 2019 and 2020, the total number of visits for new patients with malignant tumors is similar, and the stage distribution of these cancer patients is also similar (32% in 2019 stage I, 29% in 2020; 26% in both 2019 and 2020 stage IV ).


    Since the COVID-19 pandemic, the late incidence of colorectal cancer and breast cancer has increased, while the early incidence of these cancers has been declining .


    Since the COVID-19 pandemic, the late incidence of colorectal cancer and breast cancer has increased, while the early incidence of these cancers has been declining.


    https://meetinglibrary.


    https://meetinglibrary.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.